Clinical Trial

Lymphatic Response to Resistance Exercise in Breast Cancer Survivors

Study acronym: LinfoGYM
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 2, 2023 (before its estimated July 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
The objective of this study is 1) to study the acute and chronic effect of resistance therapeutic physical exercise (RTPE) in the prevention of breast cancer-related lymphedema (BCRL) in breast cancer survivors at risk using variables related to the lymphatic response; 2) Study the possible relationship between changes in body composition at a local and regional level and volume changes produced by RTPE in patients at risk of suffering from BCRL.
Trial Details
NCT Number NCT06113627
Lead Sponsor University of Malaga
Conditions Breast Cancer Lymphedema, Survivorship, Lymphedema of Upper Limb
Enrollment 170 participants
Start Date 2024-08
Primary Completion 2025-07-15 (estimated)
Study Completion 2027-01-15 (estimated)
Updated on ClinicalTrials.gov 2023-11-02